Natco Pharma has launched the Semaglutide injection in India on the first day of its patent expiry. Hyderabad-based Natco received approval from Central Drugs Standard Control Organisation (CDSCO) to ...

India’s drug regulator has intensified checks on GLP-1 weight-loss drugs like semaglutide, targeting illegal sales, ...

Lupin will gain semi-exclusive co-marketing rights for Zydus’ semaglutide injection in India under Semanext and Livarise, while Zydus retains its brands Semaglyn, Mashema and Alterme. Managing ...

Alkem Laboratories is all set to launch a semaglutide injection under the brand names Semasize, Obesema and Hepaglide priced ...

Sun Pharma will launch generic semaglutide injection under the brand name, Noveltreat. Ganorkar added, "Noveltreat meets global quality standards and is supported by robust Indian clinical evidence on ...

Multiple companies have introduced their own versions of semaglutide, signalling the beginning of a highly competitive and ...

Emcure slashes semaglutide injection price by 55%, prompting potential moves from Abbott to follow suit in India.

Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, ...

Natco Pharma said the multi-dose vial format is priced around 70% lower than pen devices and nearly 90% cheaper than the ...

Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to ...